Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: A prospective study

Gastroenterologie Clinique et Biologique

Volumn 32, Issue 2, 2008, Pages 180-187

  Adhoute, X ^a   Foucher, J ^a   Laharie, D ^a   Terrebonne, E ^a   Vergniol, J ^a   Castera L ^a   Lovato, B ^a   Chanteloup, E ^a   Merrouche, W ^a   Couzigou, P ^a   de Ledinghen V ^a,b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOLYSIS; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; NON INVASIVE PROCEDURE; PREVALENCE;

AGE FACTORS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; COHORT STUDIES; CYSTEINE; ELASTICITY IMAGING TECHNIQUES; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEMOCHROMATOSIS; HOMOZYGOTE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TYROSINE;

EID: 43049162487     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2007.12.021     Document Type: Article

References (37)

1. Olynyk J.K., Cullen D.J., Aquilia S., Rossi E., Summerville L., and Powell L.W. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341 (1999) 718-724
2. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 350 (2004) 2383-2397
3. Merryweather-Clarke A.T., Pointon J.J., Shearman J.D., and Robson K.J. Global prevalence of putative haemochromatosis mutations. J Med Genet 34 (1997) 275-278
4. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13 (1996) 399-408
5. Beaton M., Guyader D., Deugnier Y., Moirand R., Chakrabarti S., and Adams P. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 36 (2002) 673-678
6. Villeneuve J.P., Bilodeau M., Lepage R., Cote J., and Lefebvre M. Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 25 (1996) 172-177
7. Gandon Y., Olivie D., Guyader D., Aube C., Oberti F., Sebille V., et al. Noninvasive assessment of hepatic iron stores by MRI. Lancet 363 (2004) 357-362
8. Maharaj B., Maharaj R.J., Leary W.P., Cooppan R.M., Naran A.D., Pirie D., et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1 (1986) 523-525
9. Regev A., Berho M., Jeffers L.J., Milikowski C., Molina E.G., Pyrsopoulos N.T., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97 (2002) 2614-2618
10. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
11. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 (2003) 518-526
12. Sterling R.K., Lissen E., Clumeck N., Sola R., Correa M.C., Montaner J., et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 43 (2006) 1317-1325
13. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., and Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357 (2001) 1069-1075
14. Adams L.A., Bulsara M., Rossi E., DeBoer B., Speers D., George J., et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 51 (2005) 1867-1873
15. Forns X., Ampurdanes S., Llovet J.M., Aponte J., Quinto L., Martinez-Bauer E., et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36 (2002) 986-992
16. Lok A.S., Ghany M.G., Goodman Z.D., Wright E.C., Everson G.T., Sterling R.K., et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 42 (2005) 282-292
17. Islam S., Antonsson L., Westin J., and Lagging M. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers. Scand J Gastroenterol 40 (2005) 867-872
18. de Ledinghen V., Douvin C., Kettaneh A., Ziol M., Roulot D., Marcellin P., et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 41 (2006) 175-179
19. Castera L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haaser M., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
20. Ziol M., Handra-Luca A., Kettaneh A., Christidis C., Mal F., Kazemi F., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 (2005) 48-54
21. Laharie D., Zerbib F., Adhoute X., Boue-Lahorgue X., Foucher J., Castera L., et al. Diagnosis of liver fibrosis by transient elastography (FibroScan) and noninvasive methods in Crohn's disease patients treated with methotrexate. Aliment Pharmacol Ther 23 (2006) 1621-1628
22. Foucher J., Chanteloup E., Vergniol J., Castera L., Le Bail B., Adhoute X., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55 (2006) 403-408
23. Corpechot C., El Naggar A., Poujol-Robert A., Ziol M., Wendum D., Chazouilleres O., et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 43 (2006) 1118-1124
24. Carrion J.A., Navasa M., Bosch J., Bruguera M., Gilabert R., and Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 12 (2006) 1791-1798
25. Fontaine H., Petitprez K., Roudot-Thoraval F., and Trinchet J.C. Guidelines for the diagnosis of uncomplicated cirrhosis. Gastroenterol Clin Biol 31 (2007) 504-509
26. de Ledinghen V., Ratziu V., Causse X., Bail B.L., Capron D., Renou C., et al. Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. J Hepatol 45 (2006) 592-599
27. Sandrin L., Fourquet B., Hasquenoph J.M., Yon S., Fournier C., Mal F., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29 (2003) 1705-1713
28. Ganne-Carrie N., Ziol M., de Ledinghen V., Douvin C., Marcellin P., Castera L., et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 44 (2006) 1511-1517
29. Cadranel J., Rufat P., and Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 32 (2000) 477-481
30. Bravo A.A., Sheth S.G., and Chopra S. Liver biopsy. N Engl J Med 344 (2001) 495-500
31. Colloredo G., Guido M., Sonzogni A., and Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 39 (2003) 239-244
32. Jensen P.D., Heickandorff L., Helweg-Larsen H.M., Jensen F.T., Christensen T., and Ellegaard J. Serum procollagen III peptide concentration in iron overload. Eur J Haematol 57 (1996) 157-164
33. Guyader D., Jacquelinet C., Moirand R., Turlin B., Mendler M.H., Chaperon J., et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 115 (1998) 929-936
34. Morrison E.D., Brandhagen D.J., Phatak P.D., Barton J.C., Krawitt E.L., El-Serag H.B., et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 138 (2003) 627-633
35. Kazemi F., Kettaneh A., N'kontchou G., Pinto E., Ganne-Carrié N., Trinchet J., et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 45 (2006) 230-235
36. Adams L.A., Angulo P., Abraham S.C., Torgerson H., and Brandhagen D. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis. Liver Int 26 (2006) 298-304
37. Adams L.A., Sanderson S., Lindor K.D., and Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 42 (2005) 132-138